On September 25, 2017, the US Food and Drug Administration (FDA) published final guidance—entitled Classification of Products as Drugs and Devices & Additional Product Classification Issues ...
Every 5 or 10 years, Congress enacts major legislation addressing pressing issues at the Food and Drug Administration (FDA). This year, the biggest reforms since at least 1997 are expected. A decade ...
This systematic literature review reports incidence of adverse drug effects associated with guideline-directed medical therapy for patients with heart failure with reduced ejection fraction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback